Digital Contract

How many HCC patients do you see on an average in a year for ablation therapy? *

Among all the HCC patients you treat, what% patients are referred by *

Hepatologist/Hepatobilliary Surgeons	%
--}} {{-- Stage-II --}} {{--	--}} {{-- --}} {{-- --}} {{-- % --}} {{-- --}} {{--
Gastroenterologist	%
Oncologist	%
Direct	%

Of these patients what % of patients are TARE eligible? *

What would be the stage wise split of HCC patients in your practice? *

How many CRC patients do you see in a year with liver only metastates? *

Do you use Y90 therapy for CRC with liver mets disease? *

Yes

No

Of all HCC patients that you see, what % of patients present with *

When an HCC TARE eligible patient with Bilobar disease is undergoing Y90 therapy, amongst the following options what is your choice of treatment? *

Treat both lobes in one treatment procedure.

Treat both lobes in different treatment procedures within a gap of 4-6 weeks.

If there are 3 or less nodules in both lobes, I choose option (a).

Any other

In your clinical practice of Y90 therapy for HCC, what is a commonly seen range of tumour size? *

cm

When it come to selecting a Y90 formulation which amongst the following is your preference? *

Y90 glass beads

Y90 resin-based beads

Do you use systemic therapy along with the TARE treatment? *

Yes

No

If yes then which patient group are more benefited

In hyper vascular tumour, what is your choice of treatment (Tick one of the options)? *

Glass Microsphere

Resin Microsphere

In hypo vascular tumour, what is your choice of treatment (Tick one of the options)? *

Glass Microsphere

Resin Microsphere

How frequently do you need to change the pre-calculated dose of SirSphere from the MAA scan just before the administration day? *

Yes, very common

Sometimes

Rare

Never

Given an option, would you like to do the MAA scan and Sirsphere treatment on the same day? *

YES

NO

Are you aware of the flex dose delivery program of Sirsphere? *

YES

NO